Applied DNA Sciences, Inc.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
03815U409
SEDOL
N/A
CIK
0000744452
www.adnas.com
LEI:
©
New: Infographics X-Lab
FIGI: -
APDN
Applied DNA Sciences, Inc.
GICS: - · Sektor: Healthcare · Sub-Sektor: Diagnostics & Research
AI
PROFILER
NAME
Applied DNA Sciences, Inc.
ISIN
US03815U4094
TICKER
APDN
MIC
XNAS
REUTERS
APDN.OQ
BLOOMBERG
APDN US
F&G: 75
6.254,96 S&P · 17,28 Vola-Index · 118.810,91 BTC · 1,16904 EURUSD
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von ACCESS Newswire bereitgestellt.
Mo., 30.06.2025       Applied DNA Sciences
US03815U4094

- Conducts 27% Workforce Reduction, Ceases Operations at Applied DNA Clinical Labs, Positions LineaRx for Growth - STONY BROOK, NY / ACCESS Newswire / June 30, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN), a leader in PCR-based DNA technologies, announced a strategic restructuring and realignment of resources to focus exclusively on its syntheti...
Read More
Applied DNA Sciences
Technical Analysis Termsheet Terminal
Permalink
Mo., 16.06.2025       Applied DNA Sciences
US03815U4094

STONY BROOK, NY / ACCESS Newswire / June 16, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will resume a regular quarterly investor call schedule, beginning with the release of its fiscal third quarter 2025 financial results in mi...
Read More
Applied DNA Sciences
Technical Analysis Termsheet Terminal
Permalink
Mi., 26.03.2025       Applied DNA Sciences
US03815U4094

STONY BROOK, NY / ACCESS Newswire / March 26, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that Applied DNA Clinical Labs (ADCL), the Company's wholly-owned clinical laboratory subsidiary, has submitted a validation package to the New York State Dep...
Read More
Applied DNA Sciences
Technical Analysis Termsheet Terminal
Permalink
Mi., 12.03.2025       Applied DNA Sciences
US03815U4094

STONY BROOK, NY / ACCESS Newswire / March 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-50 reverse stock split of its issued and outstanding common stock. The Reverse Stock Split will become effective at 12:01 a.m. Eas...
Read More
Applied DNA Sciences
Technical Analysis Termsheet Terminal
Permalink
Do., 13.02.2025       Applied DNA Sciences
US03815U4094

- Announces Exit of DNA Tagging and Security Products and Services Business Segment -- Workforce Reduction of 20% of Headcount Implemented in January -- GMP Site 1 Facility Complete and Certified for Commercial Operation in January -- Webcast and Conference Call Scheduled for today at 4:30 PM ET - STONY BROOK, NY / ACCESS Newswire / February 13, 20...
Read More
Applied DNA Sciences
Technical Analysis Termsheet Terminal
Permalink
Mi., 12.02.2025       Applied DNA Sciences
US03815U4094

Investor Call and Webcast Scheduled for 4:30 P.M ET STONY BROOK, NY / ACCESS Newswire / February 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its first quarter fiscal 2025 financial result...
Read More
Applied DNA Sciences
Technical Analysis Termsheet Terminal
Permalink
Di., 11.02.2025       Applied DNA Sciences
US03815U4094

STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to its shareholders to vote ahead of a reconvening of a Special Meeting of Stockholders (the "Special Meeting") to be held on...
Read More
Applied DNA Sciences
Technical Analysis Termsheet Terminal
Permalink
Fr., 10.01.2025       Applied DNA Sciences
US03815U4094

- Signals Start of New Commercialization Phase for LineaRx Subsidiary -- Company Negotiating GMP Supply Agreement -- Company Reaffirms Strategic Restructuring Timeline - STONY BROOK, NY / ACCESSWIRE / January 10, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technolog...
Read More
Applied DNA Sciences
Technical Analysis Termsheet Terminal
Permalink
Mi., 08.01.2025       Applied DNA Sciences
US03815U4094

STONY BROOK, NY / ACCESSWIRE / January 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it has rescheduled its Investor Update call to Thursday, February 13, 2025, to coincide with the release of its first qua...
Read More
Applied DNA Sciences
Technical Analysis Termsheet Terminal
Permalink
Mi., 18.12.2024       Applied DNA Sciences
US03815U4094

- Regulatory Approval Showcases Clinical Advancement of Linea DNA™ as a Rapid and Effective Means of Producing CAR-T cell Therapies -STONY BROOK, NY / ACCESSWIRE / December 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, announced that the State ...
Read More
Applied DNA Sciences
Technical Analysis Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

BARRISTA SMART * AD

P R O D U C T   S U G G E S T I O N S